Plexus Corp. (NASDAQ:PLXS - Get Free Report) CAO Angelo Michael Ninivaggi, Jr. sold 3,423 shares of the company's stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $145.14, for a total transaction of $496,814.22. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $4,281,775.14. This trade represents a 10.40 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.
Shares of NASDAQ PLXS traded down $1.62 during midday trading on Friday, reaching $141.71. 192,061 shares of the company's stock were exchanged, compared to its average volume of 180,248. The stock has a market capitalization of $3.84 billion, a PE ratio of 32.88 and a beta of 0.91. Plexus Corp. has a 52-week low of $90.18 and a 52-week high of $172.89. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.70 and a current ratio of 1.53. The business's fifty day moving average price is $160.77 and its two-hundred day moving average price is $142.91.
Plexus (NASDAQ:PLXS - Get Free Report) last announced its quarterly earnings data on Wednesday, January 22nd. The technology company reported $1.49 earnings per share for the quarter, missing the consensus estimate of $1.59 by ($0.10). Plexus had a return on equity of 10.36% and a net margin of 3.03%. Analysts forecast that Plexus Corp. will post 5.97 EPS for the current year.
Institutional investors have recently modified their holdings of the business. Blue Trust Inc. increased its position in Plexus by 12.1% in the fourth quarter. Blue Trust Inc. now owns 776 shares of the technology company's stock worth $121,000 after buying an additional 84 shares during the period. Glenmede Trust Co. NA boosted its stake in Plexus by 4.4% during the 3rd quarter. Glenmede Trust Co. NA now owns 2,453 shares of the technology company's stock valued at $335,000 after purchasing an additional 104 shares during the period. GAMMA Investing LLC increased its stake in shares of Plexus by 17.2% in the fourth quarter. GAMMA Investing LLC now owns 891 shares of the technology company's stock valued at $139,000 after purchasing an additional 131 shares during the period. Farrow Financial Inc. raised its holdings in shares of Plexus by 0.7% during the third quarter. Farrow Financial Inc. now owns 21,692 shares of the technology company's stock valued at $2,966,000 after buying an additional 155 shares during the last quarter. Finally, Quarry LP grew its holdings in Plexus by 573.5% in the 3rd quarter. Quarry LP now owns 229 shares of the technology company's stock worth $31,000 after buying an additional 195 shares in the last quarter. Institutional investors own 94.45% of the company's stock.
A number of brokerages have weighed in on PLXS. Benchmark reiterated a "buy" rating and issued a $165.00 price target on shares of Plexus in a report on Wednesday, January 22nd. Needham & Company LLC boosted their price target on Plexus from $162.00 to $172.00 and gave the company a "buy" rating in a research report on Friday, January 24th. KeyCorp assumed coverage on Plexus in a report on Tuesday, October 22nd. They set a "sector weight" rating for the company. Stifel Nicolaus lifted their price target on shares of Plexus from $136.00 to $150.00 and gave the company a "hold" rating in a research report on Tuesday, December 10th. Finally, StockNews.com raised shares of Plexus from a "hold" rating to a "buy" rating in a research report on Monday, November 18th. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $162.33.
Read Our Latest Research Report on PLXS
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Plexus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.
While Plexus currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.